We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

IRESSA Receives Marketing Authorization for the Treatment of Non-Small Cell Lung Cancer in Europe

News   Jul 07, 2009

 
IRESSA Receives Marketing Authorization for the Treatment of Non-Small Cell Lung Cancer in Europe
 
 
Advertisement
 

RELATED ARTICLES

Experts Respond to Reported Death of COVID-19 Vaccine Trial Participant

News

News has emerged from Brazil that a participant of the Phase III clinical trial investigating the COVID-19 vaccine, ChAdOX1, has died.

READ MORE

Synthesizing Bacteria-Killing Molecules From Wasp Venom

News

A team of researchers has engineered powerful new antimicrobial molecules from toxic proteins originally found in wasp venom.

READ MORE

Ultrapotent Compound Could Help Combat C. difficile

News

Scientists from Purdue University have advanced novel compounds that they have designed to help treat patients with Clostridioides difficile.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE